Thrombembolic events in patients with non-hodgkin's lymphoma And anticardiolipin antibodies
Patients with non-Hodgkin's lymphoma (NHL) have an increased risk of thromboembolic events. It is important to identify NHL patients at increased risk of developing thromboembolic complications in order to apply prophylactic treatment. Anticardiolipin antibodies are autoantibodies that mistaken...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Hematology Reports |
| Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8922 |